Nifty

:

11153.65

Sensex

:

37734.08

-96.90 (-0.86%)
-300.06 (-0.79%)

Login

Nifty
Sensex

:
:

11153.65
37734.08

-96.90 (-0.86%)
-300.06 (-0.79%)

Sun Pharma Advanced Research Company Ltd.

Pharmaceuticals & Drugs - Global

Rating :

62/99

BSE: 532872 | NSE: SPARC

Watchlist

NSE BSE

172.85

22-Sep-2020

Open
High
Low
Previous Close

173.45
175.85
167.40
168.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1420971
2450.93
210.90
81.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,528.18
N/A
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,596.07
N/A
119.00

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

2.79
-13.79
-0.62

EBITDA CAGR (%)

10 Years
5 Years
3 Years

46.89
37.45
5.03

PAT CAGR (%)

10 Years
5 Years
3 Years

43.39
34.88
16.61

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-33.60
-33.60
-33.60

EV:EBITDA (Average)

8 Years
5 Years
3 Years

2.54
-36.20
-31.58

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 185.45 17.32 970.73% 22.71 84.83 -73.23% 19.60 19.88 -1.41% 17.19 61.35 -71.98%
Expenses 124.67 112.34 10.98% 121.07 96.75 25.14% 73.31 90.26 -18.78% 80.11 66.55 20.38%
EBITDA 60.78 -95.02 - -98.36 -11.92 - -53.71 -70.38 - -62.92 -5.20 -
EBIDTM 32.77% -548.61% -0.29% -14.05% -274.03% -354.02% -366.03% -8.48%
Other Income 0.66 3.67 -82.02% 3.12 4.43 -29.57% 0.71 3.27 -78.29% 2.26 4.57 -50.55%
Interest 1.97 0.59 233.90% 1.57 0.04 3,825.00% 0.26 0.02 1,200.00% 0.25 0.01 2,400.00%
Depreciation 2.78 2.25 23.56% 2.73 1.82 50.00% 2.25 1.90 18.42% 2.25 1.94 15.98%
PBT 56.69 -94.19 - -99.54 -9.35 - -55.51 -69.03 - -63.16 -2.58 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 56.69 -94.19 - -99.54 -9.35 - -55.51 -69.03 - -63.16 -2.58 -
PATM 30.57% -543.82% 2.87% -11.02% -283.21% -347.23% -367.42% -4.21%
EPS 2.16 -3.60 - -3.80 -0.36 - -2.12 -2.63 - -2.41 -0.10 -

Description Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var% Jun 19 Jun 18 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 244.95 76.81 182.87 78.26 181.02 161.28 155.74 167.03 87.28 28.98 58.35 Net Sales Growth 33.58% -58.00% 133.67% -56.77% 12.24% 3.56% -6.76% 91.37% 201.17% -50.33% Cost Of Goods Sold 514.66 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit -269.71 76.81 182.87 78.26 181.02 161.28 155.74 167.03 87.28 28.98 58.35 GP Margin -110.11% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Total Expenditure 399.16 386.83 334.16 320.87 303.72 224.48 190.83 133.54 104.04 98.92 64.98 Power & Fuel Cost - 5.14 5.08 4.92 4.67 4.49 4.78 3.95 3.85 3.35 2.76 % Of Sales - 6.69% 2.78% 6.29% 2.58% 2.78% 3.07% 2.36% 4.41% 11.56% 4.73% Employee Cost - 93.09 81.06 100.92 84.30 56.60 45.79 40.40 36.55 30.43 25.67 % Of Sales - 121.20% 44.33% 128.95% 46.57% 35.09% 29.40% 24.19% 41.88% 105.00% 43.99% Manufacturing Exp. - 30.47 17.81 31.79 33.41 26.42 17.96 16.19 15.84 12.99 13.07 % Of Sales - 39.67% 9.74% 40.62% 18.46% 16.38% 11.53% 9.69% 18.15% 44.82% 22.40% General & Admin Exp. - 251.32 221.40 181.18 176.28 131.88 119.37 71.71 46.26 51.31 22.72 % Of Sales - 327.20% 121.07% 231.51% 97.38% 81.77% 76.65% 42.93% 53.00% 177.05% 38.94% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 6.81 8.80 2.05 5.06 5.08 2.94 1.29 1.54 0.85 0.00 % Of Sales - 8.87% 4.81% 2.62% 2.80% 3.15% 1.89% 0.77% 1.76% 2.93% 1.30% EBITDA -154.21 -310.02 -151.29 -242.61 -122.70 -63.20 -35.09 33.49 -16.76 -69.94 -6.63 EBITDA Margin -62.96% -403.62% -82.73% -310.01% -67.78% -39.19% -22.53% 20.05% -19.20% -241.34% -11.36% Other Income 6.75 9.76 13.51 4.94 13.72 2.94 3.03 10.00 1.62 1.15 1.24 Interest 4.05 2.67 0.09 0.12 1.82 2.16 0.22 5.60 3.95 0.27 0.13 Depreciation 10.01 9.48 7.55 8.18 8.24 7.58 7.24 3.57 3.40 3.16 2.99 PBT -161.52 -312.40 -145.43 -245.97 -119.04 -69.99 -39.52 34.32 -22.49 -72.23 -8.51 Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.00 0.00 0.00 -0.01 Tax Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 11.66% 0.00% 0.00% 0.12% PAT -161.52 -312.40 -145.43 -197.00 -119.04 -69.99 -39.52 30.32 -22.49 -72.23 -8.50 PAT before Minority Interest -161.52 -312.40 -145.43 -197.00 -119.04 -69.99 -39.52 30.32 -22.49 -72.23 -8.50 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -65.94% -406.72% -79.53% -251.73% -65.76% -43.40% -25.38% 18.15% -25.77% -249.24% -14.57% PAT Growth 0.00% - - - - - - - - - EPS -6.16 -11.92 -5.55 -7.52 -4.54 -2.67 -1.51 1.16 -0.86 -2.76 -0.32

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds -18.64 296.24 184.72 158.16 31.80 99.80 139.30 108.43 -66.61 5.62 Share Capital 26.21 26.21 25.09 24.69 23.67 23.67 23.67 23.66 20.71 20.71 Total Reserves -44.84 270.03 67.96 133.47 6.23 76.13 115.63 84.77 -87.32 -15.09 Non-Current Liabilities 55.85 11.20 11.98 10.36 10.02 9.72 9.45 6.32 7.23 7.48 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 6.38 1.09 1.64 2.18 2.73 3.27 3.82 4.36 5.74 6.30 Long Term Provisions 10.23 10.11 10.34 8.18 7.30 6.37 5.48 1.73 1.24 1.06 Current Liabilities 235.36 95.04 116.11 108.03 124.84 37.15 38.79 94.24 145.03 64.66 Trade Payables 158.84 82.92 102.48 94.45 58.15 27.01 29.75 12.79 16.23 10.31 Other Current Liabilities 9.78 7.66 9.42 9.81 12.09 8.98 7.58 3.79 66.06 53.17 Short Term Borrowings 61.42 0.00 0.10 0.41 52.48 0.40 0.82 75.97 61.94 0.29 Short Term Provisions 5.31 4.46 4.10 3.35 2.12 0.77 0.64 1.69 0.79 0.89 Total Liabilities 272.57 402.48 312.81 276.55 166.66 146.67 187.54 208.99 85.65 77.76 Net Block 103.86 57.56 51.74 69.16 69.96 66.79 64.49 65.55 63.93 62.93 Gross Block 135.50 80.22 67.17 77.28 106.82 96.38 86.98 84.57 79.58 75.45 Accumulated Depreciation 31.64 22.66 15.44 8.12 36.86 29.58 22.49 19.02 15.65 12.52 Non Current Assets 205.38 145.09 137.59 118.27 98.88 83.46 76.87 69.14 66.97 65.27 Capital Work in Progress 32.07 24.13 3.27 1.47 0.87 0.02 0.76 0.16 1.14 1.26 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 69.24 63.29 82.48 47.45 27.99 16.55 11.50 3.30 1.69 0.89 Other Non Current Assets 0.20 0.12 0.10 0.19 0.07 0.09 0.11 0.13 0.21 0.19 Current Assets 67.19 257.38 175.22 158.28 66.59 62.93 110.12 139.01 18.24 12.50 Current Investments 8.49 210.58 107.57 9.65 0.00 0.00 6.50 96.91 0.00 2.47 Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 16.05 10.17 17.56 38.90 9.16 19.89 28.00 25.06 4.26 2.63 Cash & Bank 0.46 0.68 1.32 70.31 12.75 17.34 6.56 6.72 6.50 5.15 Other Current Assets 42.19 2.57 2.04 1.95 44.69 25.70 69.06 10.33 7.48 2.25 Short Term Loans & Adv. 39.33 33.39 46.73 37.48 43.35 24.27 63.34 9.69 7.15 2.02 Net Current Assets -168.17 162.34 59.11 50.25 -58.24 25.79 71.33 44.77 -126.79 -52.16 Total Assets 272.57 402.47 312.81 276.55 166.65 146.67 187.55 208.99 85.64 77.77

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity -210.81 -171.91 -182.77 -128.04 -44.21 -41.17 36.90 -95.34 -69.45 2.29 PBT -312.40 -145.43 -245.97 -119.04 -69.99 -39.52 34.32 -22.49 -72.23 -8.51 Adjustment 9.44 -21.77 3.82 -1.14 9.25 4.73 0.90 5.71 2.87 2.70 Changes in Working Capital 102.02 -0.17 20.48 12.86 30.41 -3.74 9.80 -77.91 0.70 8.14 Cash after chg. in Working capital -200.95 -167.38 -221.68 -107.32 -30.34 -38.53 45.03 -94.69 -68.66 2.33 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -9.86 -4.54 -10.08 -20.72 -13.87 -2.64 -8.13 -0.65 -0.79 -0.03 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 48.98 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 155.35 -102.19 -104.62 -6.61 -13.08 53.00 43.59 -99.31 -2.42 -7.64 Net Fixed Assets -63.22 -33.91 8.31 28.94 -11.29 -8.66 -3.01 -4.01 -4.01 -4.15 Net Investments 202.09 -103.01 -97.92 -9.65 0.00 6.50 90.41 -96.91 2.47 -2.47 Others 16.48 34.73 -15.01 -25.90 -1.79 55.16 -43.81 1.61 -0.88 -1.02 Cash from Financing Activity 55.46 274.25 224.01 194.25 50.55 -1.26 -80.84 194.38 72.10 4.41 Net Cash Inflow / Outflow 0.00 0.15 -63.38 59.60 -6.74 10.57 -0.35 -0.27 0.23 -0.93 Opening Cash & Equivalents 0.35 0.20 63.58 4.00 10.63 0.01 0.33 0.57 0.34 1.27 Closing Cash & Equivalent 0.35 0.35 0.20 63.58 4.00 10.63 0.01 0.33 0.57 0.34

Financial Ratios

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) -0.71 11.30 3.71 6.41 1.21 4.18 5.82 4.52 -3.16 0.27 ROA -93.11% -40.66% -66.85% -53.72% -44.68% -23.65% 15.29% -15.27% -88.40% -11.33% ROE -225.08% -74.72% -156.84% -127.40% -109.16% -33.17% 24.62% -110.94% 0.00% -86.09% ROCE -178.22% -59.95% -113.05% -94.66% -71.37% -31.74% 24.02% -19.55% -1066.48% -58.87% Fixed Asset Turnover 0.71 2.48 1.08 1.97 1.59 1.70 1.95 1.06 0.37 0.80 Receivable days 62.28 27.67 131.66 48.45 32.87 56.11 57.97 61.31 43.42 9.80 Inventory Days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Payable days 316.55 300.15 244.72 211.37 163.03 136.14 120.80 88.65 96.96 87.32 Cash Conversion Cycle -254.27 -272.48 -113.05 -162.92 -130.16 -80.03 -62.83 -27.34 -53.54 -77.52 Total Debt/Equity -3.67 0.01 0.02 0.02 1.94 0.04 0.04 0.75 -1.02 1.17 Interest Cover -115.79 -1547.78 -1596.71 -64.41 -31.45 -180.04 7.13 -4.69 -261.76 -65.47

Top Investors:

sun pharmaceutical industries key employees benefit trust

lakshdeep investments & finance (p) ltd.

Annual Reports:

News Update:

SPARC grants exclusive license to Tripoint Therapeutics LLC, USA
22nd Sep 2020, 09:38 AM

The company will be eligible to receive tiered royalties ranging from 15% to 50% on net sales
Read More
Sun Pharma Advanced Research turns black in Q1
5th Aug 2020, 15:16 PM

Total income of the company reported over 8- fold jumps at Rs 186.11 crore for Q1FY21
Read More
Sun Pharma Adv. Res - Quarterly Results
4th Aug 2020, 20:14 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback